{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:18:35Z","timestamp":1787008715707,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IFCAH","award":["2019"],"award-info":[{"award-number":["2019"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["325768017"],"award-info":[{"award-number":["325768017"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271-TRR205"],"award-info":[{"award-number":["314061271-TRR205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Subfertility is prevalent in men with classic 21-hydroxylase deficiency (21OHD). We sought to characterize the long-term evolution of their gonadal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective longitudinal single-center study in 27 men (11 with testicular adrenal rest tissue [TART]), median observation period 12 years, testosterone (T), 11-oxygenated androgens, gonadotropins, and inhibin B measurement at each time point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>T concentrations were below the normal range (n.s.) in 43.2% (no TART) and 54.6% (TART) per patient. After accounting for body mass index, sex hormone-binding globulin, and age, men with TART exhibited higher T (14.0 \u00b1 0.80\u2005nmol\/L) than those without (11.9 \u00b1 0.71\u2005nmol\/L). During the observation period, T levels rose in both groups but more in men with TART (from 10.1 \u00b1 1.1 to 17.3 \u00b1 1.9\u2005nmol\/L vs 10.3 \u00b1 1.0 to 12.8 \u00b1 1.9\u2005nmol\/L); this was accompanied by rising luteinizing hormone and diminishing hydrocortisone equivalent dosages (TART: from 38.1 \u00b1 3.2 to 35.1 \u00b1 1.8\u2005mg\/d; vs no TART: 28.8 \u00b1 2.7 to 28.1 \u00b1 1.6\u2005mg\/d) without correlation with any markers of adrenal androgen control. Inhibin B declined in men with large TART over time while TART status remained stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>T levels below the normal range are frequent in men with 21OHD, regardless of TART, but change little over time. Besides adrenal androgen control gonadal axis suppression from supraphysiological glucocorticoid dosages needs to be considered. While our results do not endorse regular screening for alterations in TART status among adults, Sertoli cell function should be monitored in men with large TART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae112","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T09:09:39Z","timestamp":1725959379000},"page":"370-380","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-8332","authenticated-orcid":false,"given":"Matthias K","family":"Auer","sequence":"first","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"B\u00fcy\u00fckerzurmulu","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1770-4392","authenticated-orcid":false,"given":"Christian","family":"Lottspeich","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-6668","authenticated-orcid":false,"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rieger","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Nowotny","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Tschaidse","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-6181","authenticated-orcid":false,"given":"Richard J","family":"Auchus","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"Division of Metabolism, Endocrinology and Diabetes, Department Pharmacology, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-6069","authenticated-orcid":false,"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"8","key":"2024092716205769700_lvae112-B1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N Engl J Med."},{"issue":"10372","key":"2024092716205769700_lvae112-B2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","article-title":"Congenital adrenal hyperplasia","volume":"401","author":"Auer","year":"2023","journal-title":"Lancet"},{"issue":"23","key":"2024092716205769700_lvae112-B3","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.81.23.7505","article-title":"HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation","volume":"81","author":"White","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2024092716205769700_lvae112-B4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1365-2265.2006.02740.x","article-title":"Congenital adrenal hyperplasia and P450 oxidoreductase deficiency","volume":"66","author":"Krone","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024092716205769700_lvae112-B5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev."},{"issue":"3","key":"2024092716205769700_lvae112-B6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-17-0862","article-title":"Gonadal function in adult male patients with congenital adrenal hyperplasia","volume":"178","author":"Engels","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2024092716205769700_lvae112-B7","doi-asserted-by":"publisher","first-page":"105921","DOI":"10.1016\/j.jsbmb.2021.105921","article-title":"11-Oxygenated androgens and their relation to hypothalamus\u2013pituitary\u2013gonadal-axis disturbances in adults with congenital adrenal hyperplasia","volume":"212","author":"Auer","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"2024092716205769700_lvae112-B8","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1210\/jc.2016-3989","article-title":"11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency","volume":"102","author":"Turcu","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024092716205769700_lvae112-B9","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0015-0282(03)01006-9","article-title":"Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency","volume":"80","author":"Stikkelbroeck","year":"2003","journal-title":"Fertil Steril."},{"issue":"6","key":"2024092716205769700_lvae112-B10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1210\/jcem-47-6-1208","article-title":"The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia*","volume":"47","author":"Richards","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024092716205769700_lvae112-B11","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1210\/jc.2018-00736","article-title":"11-Ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7-8","key":"2024092716205769700_lvae112-B12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1159\/000513236","article-title":"The unique role of 11-oxygenated C19 steroids in both premature adrenarche and premature pubarche","volume":"93","author":"Wise-Oringer","year":"2020","journal-title":"Horm Res Paediatr."},{"issue":"5","key":"2024092716205769700_lvae112-B13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1530\/EJE-22-0320","article-title":"11-oxygenated c19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease","volume":"187","author":"Nowotny","year":"2022","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2024092716205769700_lvae112-B14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2024092716205769700_lvae112-B15","doi-asserted-by":"publisher","first-page":"E367","DOI":"10.1210\/jc.2011-1997","article-title":"Increased activation of the alternative \u201cbackdoor\u201d pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis","volume":"97","author":"Kamrath","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024092716205769700_lvae112-B16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jsbmb.2017.12.016","article-title":"Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia","volume":"178","author":"Kamrath","year":"2018","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"6","key":"2024092716205769700_lvae112-B17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/cen.13001","article-title":"Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency","volume":"84","author":"King","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2024092716205769700_lvae112-B18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1210\/jc.2008-1414","article-title":"High prevalence of reduced fecundity in men with congenital adrenal hyperplasia","volume":"94","author":"Reisch","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024092716205769700_lvae112-B19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.beem.2008.09.007","article-title":"Testicular adrenal rest tumours in congenital adrenal hyperplasia","volume":"23","author":"Claahsen-van der Grinten","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2024092716205769700_lvae112-B20","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.1210\/jc.2014-2036","article-title":"Molecular characterization of testicular adrenal rest tumors in congenital adrenal hyperplasia: lesions with both adrenocortical and Leydig cell features","volume":"100","author":"Smeets","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024092716205769700_lvae112-B21","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024092716205769700_lvae112-B22","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1210\/jc.2007-0383","article-title":"Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia","volume":"92","author":"Martinez-Aguayo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024092716205769700_lvae112-B23","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1210\/jcem.86.12.8090","article-title":"High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia","volume":"86","author":"Stikkelbroeck","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024092716205769700_lvae112-B24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1530\/EJE-11-0828","article-title":"Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia","volume":"166","author":"Falhammar","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024092716205769700_lvae112-B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.6065\/apem.2015.20.3.155","article-title":"Clinical manifestations of testicular adrenal rest tumor in males with congenital adrenal hyperplasia","volume":"20","author":"Yu","year":"2015","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"2024092716205769700_lvae112-B26","doi-asserted-by":"publisher","first-page":"1134133","DOI":"10.3389\/fendo.2023.1134133","article-title":"Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"14","author":"Saho","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2024092716205769700_lvae112-B27","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.1016\/j.ejmg.2022.104654","article-title":"Genotype of congenital adrenal hyperplasia patients with testicular adrenal rest tumor","volume":"65","author":"Aycan","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"4","key":"2024092716205769700_lvae112-B28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1530\/EJE-20-1154","article-title":"Semen quality and testicular adrenal rest tumour development in 46, XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement","volume":"184","author":"Rohayem","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2024092716205769700_lvae112-B29","doi-asserted-by":"publisher","first-page":"E1820","DOI":"10.1210\/jc.2012-3181","article-title":"Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency","volume":"98","author":"Reisch","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024092716205769700_lvae112-B30","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1210\/jc.2009-1929","article-title":"Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency","volume":"95","author":"Reisch","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024092716205769700_lvae112-B31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1210\/er.2018-00258","article-title":"Testicular adrenal rest tumors: current insights on prevalence, characteristics, origin, and treatment","volume":"40","author":"Engels","year":"2019","journal-title":"Endocr Rev."},{"issue":"3","key":"2024092716205769700_lvae112-B32","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/EJE-20-1093","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: gonadal dysfunction in congenital adrenal hyperplasia","volume":"184","author":"Claahsen-van der Grinten","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024092716205769700_lvae112-B33","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1210\/clinem\/dgab598","article-title":"Production of 11-oxygenated androgens by testicular adrenal rest tumors","volume":"107","author":"Schr\u00f6der","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024092716205769700_lvae112-B34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1530\/EJE-19-0905","article-title":"Abiraterone acetate treatment lowers 11-oxygenated androgens","volume":"182","author":"Wright","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024092716205769700_lvae112-B35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.beem.2008.10.010","article-title":"Management of the child with congenital adrenal hyperplasia","volume":"23","author":"Hindmarsh","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"2024092716205769700_lvae112-B36","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024092716205769700_lvae112-B37","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1210\/jc.2014-4124","article-title":"Clinical outcome, hormonal status, gonadotrope axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. A French national survey","volume":"100","author":"Bouvattier","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024092716205769700_lvae112-B38","doi-asserted-by":"publisher","first-page":"bvaa192","DOI":"10.1210\/jendso\/bvaa192","article-title":"11-Oxygenated androgens useful in the setting of discrepant conventional biomarkers in 21-hydroxylase deficiency","volume":"5","author":"Jha","year":"2021","journal-title":"J Endocr Soc"},{"issue":"Suppl 2","key":"2024092716205769700_lvae112-B39","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.33549\/physiolres.934508","article-title":"Glucocorticoids affect male testicular steroidogenesis","volume":"69","author":"Hampl","year":"2020","journal-title":"Physiol Res"},{"issue":"2","key":"2024092716205769700_lvae112-B40","first-page":"109","article-title":"Glucocorticoids, stress, and fertility","volume":"35","author":"Whirledge","year":"2010","journal-title":"Minerva Endocrinol"},{"issue":"8","key":"2024092716205769700_lvae112-B41","first-page":"1427","article-title":"Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy","volume":"21","author":"Martens","year":"1994","journal-title":"J Rheumatol"},{"issue":"6","key":"2024092716205769700_lvae112-B42","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1095\/biolreprod49.6.1270","article-title":"Suppression of the hypothalamic\u2013pituitary\u2013ovarian axis in normal women by glucocorticoids","volume":"49","author":"Saketos","year":"1993","journal-title":"Biol Reprod"},{"issue":"4","key":"2024092716205769700_lvae112-B43","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1210\/jc.2004-1852","article-title":"Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate","volume":"90","author":"Meriggiola","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024092716205769700_lvae112-B44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12020-022-03083-y","article-title":"The hypothalamic\u2013pituitary\u2013gonad axis in male Cushing's disease before and after curative surgery","volume":"77","author":"Zheng","year":"2022","journal-title":"Endocrine"},{"issue":"3","key":"2024092716205769700_lvae112-B45","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.fertnstert.2007.03.051","article-title":"Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage","volume":"89","author":"Claahsen-van der Grinten","year":"2008","journal-title":"Fertil Steril."}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae112\/59238374\/lvae112.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/3\/370\/59376235\/lvae112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/3\/370\/59376235\/lvae112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T12:21:47Z","timestamp":1727439707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/191\/3\/370\/7765165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae112","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,30]]}}}